2.52 USD
↘ 0.06 (2.33%)AT CLOSE (03:59 PM EDT)
OnKure Therapeutics, Inc. Class A Common Stock
OKURNASDAQ • USD
2.53
↗ 0.01 (0.20%)
POST MARKET (AS OF 07:31 PM EDT)
Post Market
AS OF 07:31 PM EDT
2.53
↗ 0.01 (0.20%)
Market: CLOSED
Shares of OnKure Therapeutics, Inc. Class A Common Stock (OKUR) are trading at $2.52. Our models show a "Sell" technical signal alongside a "Neutral" fundamental rating. Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On the valuation side, OKUR appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Oct 23, 2026.
Open?$2.62
High?$2.62
Low?$2.48
Prev. Close?$2.58
Volume?240.9K
Avg. Volume?368.2K
VWAP?$2.53
Rel. Volume?0.65x
Bid / Ask
Bid?$2.40 × 500
Ask?$3.56 × 1.2K
Spread?$1.16
Midpoint?$2.98
Valuation & Ratios
Market Cap?102.1M
Shares Out?N/A
Float?24.9M
Float %?61.7%
P/E Ratio?N/A
P/B Ratio?0.59
EPS?-$1.45
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. The company uses a structure-based drug design platform to develop a pipeline of drug candidates aimed at optimizing efficacy and tolerability. The company has multiple programs focused on targeting oncogenic PI3Kα. Its flagship program is OKI-219. The company operates in one operating segment: clinical research.
Employees
45
Market Cap
102.1M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2024-10-07
Address
6707 WINCHESTER CIRCLE, SUITE 400
BOULDER, CO 80301
Phone: (720) 307-2892
BOULDER, CO 80301
Phone: (720) 307-2892
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?65
Short Sent.?54
Piotroski F-Score?0/9Weak
Altman Z-Score?6.54Safe
Confidence?36%Very Low
Short InterestModerate
Short % of Float?4.91%Low
Short Interest?1.2M
Days to Cover?4.8
Free Float24.9M
Avg Daily Volume257.1K
Settlement Date2026-09-30
Financial Health
Current Ratio?26.75Strong
Quick Ratio?26.75Strong
Cash Ratio?25.06Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?0.59CHEAP▾
Peers100
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?1.0CHEAP▾
Peers100
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-34.1%WEAK▾
S&P5
ROA?-32.7%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-47864000
Enterprise Value?$-64451301
Fundamentals ratios updated end of day